Profiel
Scott Youmans is currently the Senior Vice President-Technical Operations at Impel Pharmaceuticals, Inc. Previously, he was the Chief Operating Officer at Atossa Therapeutics, Inc. from 2015 to 2016.
He also held the position of Vice President-Engineering at Pathway Medical Technologies, Inc. Mr. Youmans completed his undergraduate degree at Western Washington University.
Actieve functies van Scott Youmans
| Bedrijven | Functie | Begin |
|---|---|---|
| IPI LEGACY LIQUIDATION CO | Hoofd Techniek/Wetenschap/O&O | - |
Eerdere bekende functies van Scott Youmans
| Bedrijven | Functie | Einde |
|---|---|---|
| ATOSSA THERAPEUTICS, INC. | Operationeel Directeur | 12-02-2016 |
Pathway Medical Technologies, Inc.
Pathway Medical Technologies, Inc. Medical SpecialtiesHealth Technology Manufactures, develops and markets medical devices for treatment of arterial disease | Corporate Officer/Principal | - |
Opleiding van Scott Youmans
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
Impel Pharmaceuticals, Inc.
Impel Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a late-stage biopharmaceutical company focused on developing transformative therapies for central nervous system disorders | Health Technology |
Atossa Therapeutics, Inc.
Atossa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics and delivery methods for the treatment of breast cancer & other breast conditions | Health Technology |
Pathway Medical Technologies, Inc.
Pathway Medical Technologies, Inc. Medical SpecialtiesHealth Technology Manufactures, develops and markets medical devices for treatment of arterial disease | Health Technology |
Western Washington University
Western Washington University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
















